Stephens Inc. AR Grows Stock Holdings in Intuitive Surgical, Inc. $ISRG

Stephens Inc. AR boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.4% during the second quarter, Holdings Channel.com reports. The firm owned 9,073 shares of the medical equipment provider’s stock after acquiring an additional 299 shares during the period. Stephens Inc. AR’s holdings in Intuitive Surgical were worth $4,930,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Norway Savings Bank raised its stake in shares of Intuitive Surgical by 53.4% in the second quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock valued at $1,420,000 after acquiring an additional 910 shares during the period. IronOak Wealth LLC. purchased a new stake in shares of Intuitive Surgical in the second quarter valued at $1,099,000. Trust Co. of Oklahoma purchased a new stake in shares of Intuitive Surgical in the second quarter valued at $363,000. Neville Rodie & Shaw Inc. raised its stake in shares of Intuitive Surgical by 11.9% in the second quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock valued at $5,666,000 after acquiring an additional 1,110 shares during the period. Finally, Sax Wealth Advisors LLC raised its stake in shares of Intuitive Surgical by 218.1% in the second quarter. Sax Wealth Advisors LLC now owns 2,456 shares of the medical equipment provider’s stock valued at $1,334,000 after acquiring an additional 1,684 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 0.9%

NASDAQ ISRG opened at $462.74 on Wednesday. The company’s 50-day moving average price is $454.39 and its 200-day moving average price is $495.58. The stock has a market cap of $165.88 billion, a PE ratio of 64.54, a PEG ratio of 4.81 and a beta of 1.61. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. During the same period in the prior year, the business earned $1.84 EPS. The firm’s quarterly revenue was up 22.9% on a year-over-year basis. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of the stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the transaction, the executive vice president directly owned 353 shares in the company, valued at $173,845.44. This represents a 92.73% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the transaction, the insider owned 19,827 shares in the company, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 45,224 shares of company stock worth $21,716,492 in the last three months. Corporate insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the topic of several recent analyst reports. UBS Group set a $529.00 target price on shares of Intuitive Surgical in a research note on Monday, October 13th. Robert W. Baird reduced their target price on shares of Intuitive Surgical from $600.00 to $536.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 15th. Wells Fargo & Company upped their price target on shares of Intuitive Surgical from $559.00 to $599.00 and gave the stock an “overweight” rating in a report on Wednesday, July 23rd. Sanford C. Bernstein restated an “outperform” rating and issued a $685.00 price target on shares of Intuitive Surgical in a report on Tuesday. Finally, Truist Financial cut their price target on shares of Intuitive Surgical from $600.00 to $525.00 and set a “buy” rating on the stock in a report on Wednesday, October 15th. Fifteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $585.05.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.